DR.TE is a German company specializing in high cohesion reverse cross-linked homogeneous gel hyaluronic acid. The German NMI Institute is a member of the Baden-Württemberg Innovation Alliance in Germany, and cooperates with the University of Tübingen cooperate. As a non-profit organization, the institute receives 10% of its annual funding from the state government, 40% from competitive project funds from the German Federal Ministry of Science and Technology, and 50% from corporate customers. DR.TE adopts German NMI patented technology, German original HOPM fully automated production equipment, and was put into production at a Chinese scientific research institute that has specialized in hyaluronic acid for 30 years.
DR.TE has been strictly certified by the China CFDA and the National Food and Drug Administration. It is a German-made gel-type cross-linked sodium hyaluronate gel for injection, often also known as hyaluronic acid. DR.TE contour shaping aesthetics is based on the characteristics of Asian facial bone and tissue development, combined with Asian emotions, behavioral habits, etc., to design an aesthetic plan to match the needs of customers with facial contour shaping with appropriate hyaluronic acid facial solutions to meet the needs of customers. Meet the injection needs of different parts of the face of beauty seekers.
This product has the characteristics of non-displacement and non-diffusion, long-lasting and stable effect, strong resistance to enzymatic hydrolysis and free radical decomposition, safe and reliable, closest to the human body's own properties, reverse cross-linking technology, endotoxin and cross-linking agent. , The protein residue is 2-3 times lower than the national standard. The incidence of adverse reactions is <1‰. Unique reverse-phase cross-linking technology minimizes inflammation-inducing substances such as proteins and endotoxins. The residual amount of cross-linking agent is less than 0.8ppm, which is 75% lower than the national standard. DR.TE is produced using the German NMI patented process and the German original HOPM fully automated production technology to produce a cross-linking agent with less reverse-phase cross-linking and a higher degree of cross-linking; the homogeneous gel has stronger resistance to enzymatic degradation. , overall, stable and durable. The production adopts GMP 100,000-level and 10,000-level sterile production workshops, which enhances the ductility and long-lasting effectiveness of hyaluronic acid. The syringe adopts BD explosion-proof needle technology: pushing force 12N, saving time and effort, precise injection, and low pain.
Note: It should not be performed at the same time as chemical peeling, laser or scar removal surgery. A certain time interval should be ensured between the second type of surgery. It is contraindicated in patients with a history of severe allergies and those who are prone to hypertrophic scars after injection of sodium hyaluronate. It is contraindicated in patients with abnormal coagulation mechanism or patients who have received thrombolytic agents, anticoagulants or platelet coagulation inhibitors within 2 weeks. Do not use on areas where permanent fillers have been injected, where non-permanent fillers have been used 6-12 months ago, or where facial fillers have been injected.
Registration status
DR.TE registration number 60806279 was a trademark application submitted to the State Trademark Administration on November 23, 2021, and the trademark was successfully registered on May 21, 2022.
Insurance company underwriting
DR.TE was underwritten by PICC Property and Casualty Co., Ltd. on June 6, 2023 (PZMN202332110000000002).